Isabelle Borget

7.7k total citations · 2 hit papers
168 papers, 4.4k citations indexed

About

Isabelle Borget is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Economics and Econometrics. According to data from OpenAlex, Isabelle Borget has authored 168 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Endocrinology, Diabetes and Metabolism, 42 papers in Surgery and 42 papers in Economics and Econometrics. Recurrent topics in Isabelle Borget's work include Thyroid Cancer Diagnosis and Treatment (45 papers), Health Systems, Economic Evaluations, Quality of Life (35 papers) and Thyroid and Parathyroid Surgery (22 papers). Isabelle Borget is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (45 papers), Health Systems, Economic Evaluations, Quality of Life (35 papers) and Thyroid and Parathyroid Surgery (22 papers). Isabelle Borget collaborates with scholars based in France, Italy and United States. Isabelle Borget's co-authors include Martin Schlumberger, Sophie Leboulleux, Nicolas Martelli, Patrice Prognon, Judith Pineau, Hélène van den Brink, Désirèe Deandreis, Éric Baudin, Carole Serrano and Salma El Batti and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Isabelle Borget

153 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advantages and disadvantages of 3-dimensional printing in surgery: A systematic review

2016 486 citations Nicolas Martelli, Hélène van den Brink et al. profile →
Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer

2012 448 citations Martin Schlumberger, Bogdan Catargi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isabelle Borget France	32	1.9k	1.6k	975	654	651	168	4.4k
David P. Check United States	18	1.4k 0.7×	817 0.5×	1.0k 1.0×	279 0.4×	563 0.9×	24	3.7k
Simone Maurea Italy	29	512 0.3×	1.1k 0.7×	337 0.3×	446 0.7×	383 0.6×	159	2.9k
Laura D. Locati Italy	38	1.3k 0.7×	2.9k 1.8×	2.8k 2.9×	552 0.8×	1.1k 1.7×	204	6.0k
Bjørn Edwin Norway	47	497 0.3×	3.9k 2.4×	2.8k 2.9×	253 0.4×	1.9k 3.0×	246	6.5k
Rob H.A. Verhoeven Netherlands	35	539 0.3×	2.5k 1.5×	1.5k 1.5×	503 0.8×	1.7k 2.6×	213	4.6k
F. Porpiglia Italy	53	1.3k 0.7×	3.7k 2.3×	1.1k 1.1×	1.3k 2.0×	5.7k 8.8×	289	9.2k
Sébastien Gaujoux France	42	707 0.4×	3.3k 2.0×	2.9k 3.0×	657 1.0×	1.2k 1.8×	212	5.3k
Cristian Fiori Italy	45	567 0.3×	2.3k 1.4×	927 1.0×	362 0.6×	4.6k 7.1×	305	6.8k
Primož Strojan Slovenia	49	319 0.2×	3.1k 1.9×	2.5k 2.6×	774 1.2×	1.9k 2.9×	244	7.9k
John Th. M. Plukker Netherlands	50	1.1k 0.6×	4.7k 2.9×	2.5k 2.6×	454 0.7×	5.2k 8.0×	177	9.2k

Countries citing papers authored by Isabelle Borget

Since Specialization

Citations

This map shows the geographic impact of Isabelle Borget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Borget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Borget more than expected).

Fields of papers citing papers by Isabelle Borget

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Borget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Borget. The network helps show where Isabelle Borget may publish in the future.

Co-authorship network of co-authors of Isabelle Borget

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Borget. A scholar is included among the top collaborators of Isabelle Borget based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Borget. Isabelle Borget is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Italiano, Antoine, Jakob Dupont, Tarek Assi, et al.. (2025). The correlation of liquid biopsy genomic data to radiomics in colon, pancreatic, lung and prostatic cancer patients. European Journal of Cancer. 226. 115609–115609. 1 indexed citations

Cartron, Guillaume, Catherine Thiéblemont, Isabelle Borget, et al.. (2024). Évaluation en vie réelle du parcours de soins des patients éligibles à un traitement par axicabtagene ciloleucel : cohorte multicentrique IMPA-CT. Bulletin du Cancer. 111(11). 1020–1029.

Gourdy, Pierre, Patrice Darmon, Isabelle Borget, et al.. (2024). Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study. Diabetes Therapy. 15(6). 1349–1360.

Borget, Isabelle, et al.. (2024). A Cost-Effectiveness Analysis of Gonadotropins Used for Ovarian Stimulation during Assisted Reproductive Technology Based on Data from the French Nationwide Claims Database (SNDS). Gynecologic and Obstetric Investigation. 90(3). 211–225.

Borget, Isabelle, et al.. (2024). Suitability of the Current Health Technology Assessment of Innovative Artificial Intelligence-Based Medical Devices: Scoping Literature Review. Journal of Medical Internet Research. 26. e51514–e51514. 12 indexed citations

Borget, Isabelle, et al.. (2024). HTA24 Adopting a Societal Perspective in Health-Economic Evaluation: A Review of 9 HTA Methodological Guidelines on How to Integrate Societal Costs. Value in Health. 27(6). S248–S248. 1 indexed citations

Huot, Laure, et al.. (2023). Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France. International Journal of Technology Assessment in Health Care. 39(1). e58–e58. 5 indexed citations

Borget, Isabelle, et al.. (2023). Assessment of Performance, Interpretability, and Explainability in Artificial Intelligence–Based Health Technologies: What Healthcare Stakeholders Need to Know. SHILAP Revista de lepidopterología. 1(2). 120–138. 35 indexed citations

Deandreis, Désirèe, Aline Maillard, Slimane Zerdoud, et al.. (2021). RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer. European Journal of Nuclear Medicine and Molecular Imaging. 48(10). 3238–3249. 8 indexed citations

10.

Brink, Hélène van den, et al.. (2020). The learning curve in transcatheter aortic valve implantation clinical studies: A systematic review. International Journal of Technology Assessment in Health Care. 36(2). 152–161. 4 indexed citations

11.

Terroir, M., Caroline Caramella, Isabelle Borget, et al.. (2019). F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients. Thyroid. 29(10). 1457–1464. 19 indexed citations

12.

Borget, Isabelle, et al.. (2019). PNS137 ORPHAN DRUGS: WHAT FACTORS IMPACT THE PRICE IN FRANCE?. Value in Health. 22. S784–S785.

13.

Guérot, Emmanuel, Delphine Wermert, Judith Pineau, et al.. (2018). Single‐use flexible bronchoscopes compared with reusable bronchoscopes: Positive organizational impact but a costly solution. Journal of Evaluation in Clinical Practice. 24(3). 528–535. 23 indexed citations

14.

Pailler, Emma, Marianne Oulhen, Isabelle Borget, et al.. (2017). Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatment in ALK -Rearranged Non–Small Cell Lung Cancer Patients. Cancer Research. 77(9). 2222–2230. 59 indexed citations

15.

Berdelou, A., Isabelle Borget, Yann Godbert, et al.. (2017). Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice. Thyroid. 28(1). 72–78. 102 indexed citations

16.

Borget, Isabelle, et al.. (2016). Economic Evaluation of Drug Wastage Impact on Healthcare Expenditures in French Hospitals. Value in Health. 19(7). A718–A718. 1 indexed citations

17.

Chouaïd, C., et al.. (2015). French Health Technology Assessment Of Antineoplastic Drugs Indicated In The Treatment Of Solid Tumours: Perspective For Future Trends. Value in Health. 18(7). A489–A489. 1 indexed citations

18.

Borget, Isabelle, Jacques Cadranel, Jean‐Pierre Pignon, et al.. (2011). Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3. European Respiratory Journal. 39(1). 172–179. 27 indexed citations

19.

Leenhardt, Laurence, Bogdan Catargi, Isabelle Borget, et al.. (2011). Comparison of four strategies of radioiodine ablation in patients with thyroid cancer with low-risk of recurrence: the randomized, prospective ESTIMABL study. 26. 3 indexed citations

20.

Borget, Isabelle, A. Vergnenègre, & C. Chouaïd. (2011). PCN109 Cost Effectiveness of First Line Tyrosine Kinase Inhibitor Treatment in Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients: A Markov Model. Value in Health. 14(7). A454–A454.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact